Ching Zhu
Managing Partner @ 6 Dimensions Capital
Ching Zhu is a Series B investor at 6 Dimensions Capital focused on Biopharma and Health Care. Ching Zhu
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Ching Zhu invests in
Stages Ching Zhu invests in
Countries Ching Zhu invests in
Investment Focus
Industry
- Biopharma 1 (50%)
- Health Care 1 (50%)
- Medical Device 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using their proprietary Mid-Field Powering technology. This technology allows the implants to be powered externally, enabling deeperand more reliable neuromodulation treatments for conditions like Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain | $12M / Series B / Feb 20, 2019 | |
|
|
NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using their proprietary Mid-Field Powering technology. This technology allows the implants to be powered externally, enabling deeperand more reliable neuromodulation treatments for conditions like Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain | $26M / Series B / Jan 24, 2018 |
Co-Investors
About 6 Dimensions Capital
6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams formed a healthcare focused investment firm with an in-depth focus and extensive coverage both in China and global market.
6 Dimensions Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ching Zhu
Managing Partner
|
|||
|
Dr. Ge Li
Founding Partner & Chairman
|
|||
|
Edward Hu
Founding Partner
|
|||
|
Hannes Thor Smárason
Venture Partner
|
|||
|
Lianyong Chen
Managing Partner and CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ching Zhu invest in?
Ching Zhu invests primarily in Biopharma, Health Care and Medical Device startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ching Zhu last invest?
The most recent investment recorded for Ching Zhu closed in Feb 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!